Hualan Bio Announces Subsidiary's RMB 20 Million Investment in Kormac Bio

Hualan Co., Ltd.Announcement on November 14: Lingqing Digital Intelligence, a wholly-owned subsidiary of the company, and Shenzhen XtalPi intend to jointly invest in Clickmab (Clickmab Biotechnology (Suzhou) Co., Ltd.) by increasing its registered capital. Among them, Lingqing Digital Intelligence plans to use 20 million yuan to subscribe for the newly increased registered capital of Clickmab, further acquiring 9.53% equity of Clickmab on a fully diluted basis after this transaction. After the completion of the transaction, Lingqing Digital Intelligence will obtain one seat on the board of directors of Clickmab and the right of first refusal to acquire Clickmab under equal conditions. Clickmab was established in 2021 and is a biotechnology enterprise incubated by XtalPi Holdings, a global leader in AI-driven innovative drug research and development, focusing on antibody design using generative AI models.